Clinical trial CICLIBIOME
CICLIBIOME : A study of the association of the microbiome with treatment outcome of CDK4/6 inhibitors in hormone receptor-positive HER2-negative breast cancer
| Cancers | |
|---|---|
| Organ | Breast |
| Trial status | Trial open for recruitment |
| Trial type |
Interventional without experimental drug
|
| Academic trial | Oui |
| Sponsor | UCL St Luc |
| BECT Identifier | B4032022000075 |
| Last update |